TW338037B - Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition - Google Patents
Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical compositionInfo
- Publication number
- TW338037B TW338037B TW085111708A TW85111708A TW338037B TW 338037 B TW338037 B TW 338037B TW 085111708 A TW085111708 A TW 085111708A TW 85111708 A TW85111708 A TW 85111708A TW 338037 B TW338037 B TW 338037B
- Authority
- TW
- Taiwan
- Prior art keywords
- inhibitory activity
- activity
- thinkening
- phosphoriesterase
- intima
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25870595 | 1995-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW338037B true TW338037B (en) | 1998-08-11 |
Family
ID=17323960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW085111708A TW338037B (en) | 1995-10-05 | 1996-09-25 | Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6143763A (zh) |
| EP (1) | EP0796248B1 (zh) |
| KR (1) | KR100230639B1 (zh) |
| CN (1) | CN1131213C (zh) |
| AR (1) | AR004686A1 (zh) |
| AT (1) | ATE204255T1 (zh) |
| AU (1) | AU690861B2 (zh) |
| CA (1) | CA2207185C (zh) |
| DE (1) | DE69614503T2 (zh) |
| ES (1) | ES2162655T3 (zh) |
| HK (1) | HK1002194A1 (zh) |
| MX (1) | MX9704145A (zh) |
| TW (1) | TW338037B (zh) |
| WO (1) | WO1997012869A1 (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1091955A1 (en) | 1998-03-31 | 2001-04-18 | Warner-Lambert Company Llc | Quinolones as serine protease inhibitors |
| CA2553915C (en) * | 2004-02-09 | 2010-06-01 | Nissan Chemical Industries, Ltd. | 3(2h)-pyridazinone compounds as vascular intimal hyperplasia inhibitor |
| KR101258422B1 (ko) * | 2005-06-08 | 2013-04-26 | 교와 가부시키가이샤 | 신규의 트리글리세리드 저하제 |
| JP5649577B2 (ja) | 2009-08-21 | 2015-01-07 | 大塚製薬株式会社 | ベンゾ［ｂ］［１，４］ジアゼピン−２，４−ジオン化合物の製造方法 |
| TWI481601B (zh) | 2009-08-21 | 2015-04-21 | Otsuka Pharma Co Ltd | 含氮化合物及藥學組成物 |
| EP2801361A4 (en) | 2012-01-05 | 2015-11-18 | Kowa Co | CONVEYOR FOR THE DEVELOPMENT OF COLLATERAL BLOOD CIRCULATION |
| EP3682886A4 (en) | 2017-09-13 | 2021-06-09 | National University Corporation Hamamatsu University School of Medicine | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AORTIC ANEURISM |
| KR20210144657A (ko) | 2019-03-13 | 2021-11-30 | 고쿠리츠다이가쿠호진 하마마츠이카다이가쿠 | 대동맥류의 치료용 의약 조성물 |
| GB202019475D0 (en) | 2020-12-10 | 2021-01-27 | Cancer Research Tech Ltd | Therapeutic compounds and their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2093633A1 (en) * | 1991-08-23 | 1993-02-24 | Seiji Sato | Carbostyril derivative and platelets aggregation inhibitory agent |
-
1996
- 1996-09-25 TW TW085111708A patent/TW338037B/zh not_active IP Right Cessation
- 1996-09-30 AR ARP960104540A patent/AR004686A1/es active IP Right Grant
- 1996-10-04 CA CA002207185A patent/CA2207185C/en not_active Expired - Fee Related
- 1996-10-04 ES ES96932816T patent/ES2162655T3/es not_active Expired - Lifetime
- 1996-10-04 AU AU71457/96A patent/AU690861B2/en not_active Ceased
- 1996-10-04 CN CN96191700A patent/CN1131213C/zh not_active Expired - Fee Related
- 1996-10-04 DE DE69614503T patent/DE69614503T2/de not_active Expired - Lifetime
- 1996-10-04 EP EP96932816A patent/EP0796248B1/en not_active Expired - Lifetime
- 1996-10-04 KR KR1019970703738A patent/KR100230639B1/ko not_active IP Right Cessation
- 1996-10-04 MX MX9704145A patent/MX9704145A/es unknown
- 1996-10-04 US US08/849,664 patent/US6143763A/en not_active Expired - Lifetime
- 1996-10-04 WO PCT/JP1996/002892 patent/WO1997012869A1/en active IP Right Grant
- 1996-10-04 AT AT96932816T patent/ATE204255T1/de active
-
1998
- 1998-02-13 HK HK98101142A patent/HK1002194A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1172478A (zh) | 1998-02-04 |
| DE69614503D1 (en) | 2001-09-20 |
| CA2207185C (en) | 2008-08-19 |
| AR004686A1 (es) | 1999-03-10 |
| HK1002194A1 (en) | 1998-08-07 |
| CN1131213C (zh) | 2003-12-17 |
| AU7145796A (en) | 1997-04-28 |
| DE69614503T2 (de) | 2002-04-11 |
| ATE204255T1 (de) | 2001-09-15 |
| CA2207185A1 (en) | 1997-04-10 |
| AU690861B2 (en) | 1998-04-30 |
| US6143763A (en) | 2000-11-07 |
| MX9704145A (es) | 1997-09-30 |
| ES2162655T3 (es) | 2002-01-01 |
| EP0796248A1 (en) | 1997-09-24 |
| EP0796248B1 (en) | 2001-08-16 |
| WO1997012869A1 (en) | 1997-04-10 |
| KR100230639B1 (ko) | 1999-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2165819A1 (en) | Dc-89 derivatives | |
| NO307053B1 (no) | 0-alkylerte rapamycinderivater samt farmasøytiske preparater inneholdende derivatene | |
| IE890906L (en) | Method of lowering the blood pressure | |
| CA2206532A1 (en) | Novel amidinonaphthyl derivative or salt thereof | |
| IL135588A0 (en) | Piperazine derivatives and pharmaceutical compositions containing the same | |
| IE870772L (en) | Steroids | |
| GB1298771A (en) | Carboxylic esters of hydroxyphenylalkanolamines | |
| WO2001034601A3 (de) | Imidazopyridinderivate als phosphodiesterase vii-hemmer | |
| TW338037B (en) | Carbostyril derivatives possessing platelet aggregation inhibitory activity, antithrombotic activity, intima thinkening, inhibitory activity and phosphoriesterase inhibitory activity, their preparation and pharmaceutical composition | |
| CA2219656A1 (en) | Antibacterial cephalosporins | |
| MA23639A1 (fr) | Derives pyrrocarbazole, leur preparation, les compositions pharmaceutiques les contenant, leur utilisation dans le traitement des tumeurs malignes. | |
| EP0612751A3 (en) | Compounds for the preparation of cephem derivatives. | |
| TW354762B (en) | Agent for prophylaxis or treatment of cataract | |
| IE880212L (en) | N15-alkyl and n15, n15-dialkyl derivatives of teicoplanin¹compounds | |
| GB1515241A (en) | Beta-lactam antibiotics | |
| IL85822A (en) | 7-alkanesulphonoamido-1,2,4,5-tetrahydro-3h-3-benzazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| AU6193498A (en) | Isoxazole derivatives | |
| AU654300B2 (en) | 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation | |
| IE780514L (en) | Morphine derivatives | |
| CA2067475A1 (en) | Carbostyril derivatives and their use | |
| CA2112061A1 (en) | Alkyl substituted heterocyclic compounds | |
| ATE285771T1 (de) | Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung | |
| HU911922D0 (en) | New medical preparations containing 3,7-diazabicyclo(3.3.1)nonane compounds | |
| NZ246598A (en) | Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds | |
| EP0487996B1 (de) | 3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |